Making up or breaking up: The tortuous role of platelet-derived growth factor in vascular ageing: Invited review

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 8, 2009, Pages 739-747

  Yang, Xiao Ping ^b   Pei, Zhao Hui ^c   Ren, Jun ^a,b  

^a UNIVERSITY OF WYOMING   (United States)

^b UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Ageing; Cell proliferation; Platelet derived growth factor; Vascular

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CALCIUM; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INOSITOL PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB;

AGING; ANGIOGENESIS; APOPTOSIS; ARTERY INTIMA PROLIFERATION; BLOOD VESSEL WALL; CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CORONARY ARTERY ATHEROSCLEROSIS; DIMERIZATION; GENE EXPRESSION; HUMAN; MITOGENESIS; PROTEIN HYDROLYSIS; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

AGING; ANIMALS; BLOOD VESSELS; CELL PROLIFERATION; HUMANS; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR;

EID: 68549115426     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05182.x     Document Type: Review

References (121)

1. Foley DL, Craig JM, Morley R et al. Prospects for epigenetic epidemiology. Am. J. Epidemiol. 2009 169 : 389 400.
2. Yang X, Sreejayan N, Ren J. Views from within and beyond: Narratives of cardiac contractile dysfunction under senescence. Endocrine 2005 26 : 127 37.
3. Ross R. Atherosclerosis: An inflammatory disease. N. Engl. J. Med. 1999 340 : 115 26.
4. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 2002 91 : 281 91.
5. Allaire E, Muscatelli-Groux B, Mandet C et al. Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation. J. Vasc. Surg. 2002 36 : 1018 26.
6. Kenagy RD, Vesti BR, Clowes AW. The urokinase receptor mediates basic fibroblast growth factor-dependent smooth muscle cell migration through baboon aortic explants. Atherosclerosis 2002 162 : 63 7.
7. Merrilees MJ, Lemire JM, Fischer JW et al. Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ. Res. 2002 90 : 481 7.
8. Kalmes A, Vesti BR, Daum G, Abraham JA, Clowes AW. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ. Res. 2000 87 : 92 8.
9. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad. Med. J. 2006 82 : 357 62.
10. Izzo Jr. JL, Mitchell GF. Aging and arterial structure-function relations. Adv. Cardiol. 2007 44 : 19 34.
11. Zhang H, Park Y, Wu J et al. Role of TNF-alpha in vascular dysfunction. Clin. Sci. 2009 116 : 219 30.
12. Park SK, Prolla TA. Lessons learned from gene expression profile studies of aging and caloric restriction. Ageing Res. Rev. 2005 4 : 55 65.
13. 2+ signaling in murine mesenteric arterial smooth muscle cells. Mech. Ageing Dev. 2006 127 : 315 23.
14. Edo MD, Andres V. Aging, telomeres, and atherosclerosis. Cardiovasc. Res. 2005 66 : 213 21.
15. Matthews C, Gorenne I, Scott S et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: Effects of telomerase and oxidative stress. Circ. Res. 2006 99 : 156 64.
16. Safar ME, Thomas F, Blacher J et al. Metabolic syndrome and age-related progression of aortic stiffness. J. Am. Coll. Cardiol. 2006 47 : 72 5.
17. Kirkwood T. Ageing: Too fast by mistake. Nature 2006 444 : 1015 17.
18. de Paula Rodrigues GH, das Eiras Tamega I, Duque G, Spinola Dias Neto V. Severe bone changes in a case of Hutchinson-Gilford syndrome. Ann. Genet. 2002 45 : 151 5.
19. Kudlow BA, Kennedy BK. Aging: Progeria and the lamin connection. Curr. Biol. 2006 16 : R652 4.
20. Mounkes LC, Stewart CL. Aging and nuclear organization: Lamins and progeria. Curr. Opin. Cell. Biol. 2004 16 : 322 7.
21. Lans H, Hoeijmakers JH. Cell biology: Ageing nucleus gets out of shape. Nature 2006 440 : 32 4.
22. Vannini N, Pfeffer U, Lorusso G, Noonan DM, Albini A. Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model. Curr. Pharm. Des. 2008 14 : 221 5.
23. Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 1973 180 : 1332 9.
24. Stemerman MB, Weinstein R, Rowe JW, Maciag T, Fuhro R, Gardner R. Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc. Natl Acad. Sci. USA 1982 79 : 3863 6.
25. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl Acad. Sci. USA 1974 71 : 1207 10.
26. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 1999 79 : 1283 316.
27. Hoch RV, Soriano P. Roles of PDGF in animal development. Development 2003 130 : 4769 84.
28. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008 22 : 1276 312.
29. Bosse Y, Thompson C, Audette K, Stankova J, Rola-Pleszczynski M. Interleukin-4 and interleukin-13 enhance human bronchial smooth muscle cell proliferation. Int. Arch. Allergy Immunol. 2008 146 : 138 48.
30. Wara AK, Mitsumata M, Yamane T, Kusumi Y, Yoshida Y. Gene expression in endothelial cells and intimal smooth muscle cells in atherosclerosis-prone or atherosclerosis-resistant regions of the human aorta. J. Vasc. Res. 2008 45 : 303 13.
31. Yang X, Thomas DP, Zhang X et al. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler. Thromb. Vasc. Biol. 2006 26 : 85 90.
32. Fredriksson L, Li H, Eriksson U. The PDGF family: Four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 2004 15 : 197 204.
33. Vinores SA, Seo MS, Derevjanik NL, Campochiaro PA. Photoreceptor-specific overexpression of platelet-derived growth factor induces proliferation of endothelial cells, pericytes, and glial cells and aberrant vascular development: An ultrastructural and immunocytochemical study. Brain Res. 2003 140 : 169 83.
34. McCaffrey TA, Nicholson AC, Szabo PE, Weksler ME, Weksler BB. Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity. J. Exp. Med. 1988 167 : 163 74.
35. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: Is it an immutable cardiovascular risk factor? Hypertension 2005 46 : 454 62.
36. Orlandi A, Bochaton-Piallat ML, Gabbiani G, Spagnoli LG. Aging, smooth muscle cells and vascular pathobiology: Implications for atherosclerosis. Atherosclerosis 2006 188 : 221 30.
37. Tallquist M, Kazlauskas A. PDGF signaling in cells and mice. Cytokine Growth Factor Rev. 2004 15 : 205 13.
38. Zhou L, Dong J, Yu M, Yin H, She M. Age-dependent increase of NF-kappaB translocation and PDGF-B expression in aortic endothelial cells of hypercholesterolemic rats. Exp. Gerontol. 2003 38 : 1161 8.
39. Choi NH, Kim JG, Yang DJ, Kim YS, Yoo MA. Age-related changes in Drosophila midgut are associated with PVF2, a PDGF/VEGF-like growth factor. Aging Cell 2008 7 : 318 34.
40. Benatti BB, Silverio KG, Casati MZ, Sallum EA, Nociti Jr. FH. Influence of aging on biological properties of periodontal ligament cells. Connect. Tissue Res. 2008 49 : 401 8.
41. Drubaix I, Giakoumakis A, Robert L, Robert AM. Preliminary data on the age-dependent decrease in basic fibroblast growth factor and platelet-derived growth factor in the human vein wall and in their influence on cell proliferation. Gerontology 1998 44 : 9 14.
42. Chin A, Zheng J, Duignan IJ, Edelberg JM. PDGF-AB-based functional cardioprotection of the aging rat heart. Exp. Gerontol. 2006 41 : 63 8.
43. Wu X, Zhou Q, Huang L et al. Ageing-exaggerated proliferation of vascular smooth muscle cells is related to attenuation of Jagged1 expression in endothelial cells. Cardiovasc. Res. 2008 77 : 800 8.
44. Vazquez-Padron RI, Lasko D, Li S et al. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice. J. Vasc. Surg. 2004 40 : 1199 207.
45. Stratton MS, Yang X, Sreejayan N, Ren J. Impact of insulin-like growth factor-I on migration, proliferation and Akt-ERK signaling in early and late-passages of vascular smooth muscle cells. Cardiovasc. Toxicol. 2007 7 : 273 81.
46. Spin JM, Nallamshetty S, Tabibiazar R et al. Transcriptional profiling of in vitro smooth muscle cell differentiation identifies specific patterns of gene and pathway activation. Physiol. Genomics 2004 19 : 292 302.
47. Dandre F, Owens GK. Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am. J. Physiol. Heart Circ. Physiol. 2004 286 : H2042 51.
48. 1 cell cycle modulation, and matrix metalloproteinase-9 regulation in mouse aortic smooth muscle cells. Arch. Biochem. Biophys. 2003 418 : 39 48.
49. Moon SK, Thompson LJ, Madamanchi N et al. Aging, oxidative responses, and proliferative capacity in cultured mouse aortic smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2001 280 : H2779 88.
50. Li Z, Cheng H, Lederer WJ, Froehlich J, Lakatta EG. Enhanced proliferation and migration and altered cytoskeletal proteins in early passage smooth muscle cells from young and old rat aortic explants. Exp. Mol. Pathol. 1997 64 : 1 11.
51. Campbell M, Allen WE, Sawyer C, Vanhaesebroeck B, Trimble ER. Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways. Circ. Res. 2004 95 : 380 8.
52. Ruiz-Torres A, Lozano R, Melon J, Carraro R. Age-dependent decline of in vitro migration (basal and stimulated by IGF-1 or insulin) of human vascular smooth muscle cells. J. Gerontol. A Biol. Sci. Med. Sci. 2003 58 : B1074 7.
53. Ruiz-Torres A, Lozano R, Melon J, Carraro R. On how insulin may influence ageing and become atherogenic throughout the insulin-like growth factor-1 receptor pathway: In vitro studies with human vascular smooth muscle cells. Gerontology 2005 51 : 225 30.
54. Chen J, Brodsky SV, Goligorsky DM et al. Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ. Res. 2002 90 : 1290 8.
55. Zheng J, Chin A, Duignan I, Won KH, Hong MK, Edelberg JM. Growth factor-mediated reversal of senescent dysfunction of ischemia-induced cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 2006 290 : H525 30.
56. Cai X. Regulation of smooth muscle cells in development and vascular disease: Current therapeutic strategies. Expert Rev. Cardiovasc. Ther. 2006 4 : 789 800.
57. Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc. Natl Acad. Sci. USA 2004 101 : 6659 63.
58. Meyer TE, Kovacs SJ, Ehsani AA, Klein S, Holloszy JO, Fontana L. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J. Am. Coll. Cardiol. 2006 47 : 398 402.
59. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993 361 : 315 25.
60. Meisenhelder J, Suh PG, Rhee SG, Hunter T. Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell 1989 57 : 1109 22.
61. Falasca M, Logan SK, Lehto VP, Baccante G, Lemmon MA, Schlessinger J. Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J. 1998 17 : 414 22.
62. Kim TJ, Kim JH, Jin YR, Yun YP. The inhibitory effect and mechanism of luteolin 7-glucoside on rat aortic vascular smooth muscle cell proliferation. Arch. Pharm. Res. 2006 29 : 67 72.
63. Liao HJ, de Los Santos J, Carpenter G. Contrasting role of phospholipase C-gamma1 in the expression of immediate early genes induced by epidermal or platelet-derived growth factors. Exp. Cell Res. 2006 312 : 807 16.
64. 2+ regulation. Cardiovasc. Res. 2005 67 : 308 16.
65. Plattner R, Irvin BJ, Guo S et al. A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma1. Nat. Cell Biol. 2003 5 : 309 19.
66. Kim TJ, Lee JH, Lee JJ et al. Corynoxeine isolated from the hook of Uncaria rhynchophylla inhibits rat aortic vascular smooth muscle cell proliferation through the blocking of extracellular signal regulated kinase 1/2 phosphorylation. Biol. Pharm. Bull. 2008 31 : 2073 8.
67. Cheng Y, Zhao Q, Liu X, Araki S, Zhang S, Miao J. Phosphatidylcholine- specific phospholipase C, p53 and ROS in the association of apoptosis and senescence in vascular endothelial cells. FEBS Lett. 2006 580 : 4911 15.
68. Schlessinger J. How receptor tyrosine kinases activate Ras. Trends Biochem. Sci. 1993 18 : 273 5.
69. Rodriguez-Viciana P, Warne PH, Dhand R et al. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994 370 : 527 32.
70. Gennaro G, Menard C, Giasson E et al. Role of p44/p42 MAP kinase in the age-dependent increase in vascular smooth muscle cell proliferation and neointimal formation. Arterioscler. Thromb. Vasc. Biol. 2003 23 : 204 10.
71. Fu M, Zhang J, Tseng YH et al. Rad GTPase attenuates vascular lesion formation by inhibition of vascular smooth muscle cell migration. Circulation 2005 111 : 1071 7.
72. Saito Y, Hojo Y, Tanimoto T, Abe J, Berk BC. Protein kinase C-alpha and protein kinase C-epsilon are required for Grb2-associated binder-1 tyrosine phosphorylation in response to platelet-derived growth factor. J. Biol. Chem. 2002 277 : 23 216 22.
73. Waters CM, Connell MC, Pyne S, Pyne NJ. c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells. Cell Signal. 2005 17 : 263 77.
74. Vanhaesebroeck B, Leevers SJ, Panayotou G, Waterfield MD. Phosphoinositide 3-kinases: A conserved family of signal transducers. Trends Biochem. Sci. 1997 22 : 267 72.
75. Andersson M, Ostman A, Backstrom G et al. Assignment of interchain disulfide bonds in platelet-derived growth factor (PDGF) and evidence for agonist activity of monomeric PDGF. J. Biol. Chem. 1992 267 : 11 260 6.
76. Dell S, Peters S, Muther P, Kociok N, Joussen AM. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 2006 47 : 1928 37.
77. Chiou YL, Shieh JJ, Lin CY. Blocking of Akt/NF-kappaB signaling by pentoxifylline inhibits platelet-derived growth factor-stimulated proliferation in Brown Norway rat airway smooth muscle cells. Pediatr. Res. 2006 60 : 657 62.
78. Mellgren AM, Smith CL, Olsen GS et al. Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations. Circ. Res. 2008 103 : 1393 401.
79. Tortorella C, Simone O, Piazzolla G, Stella I, Cappiello V, Antonaci S. Role of phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways in granulocyte macrophage-colony-stimulating factor failure to delay fas-induced neutrophil apoptosis in elderly humans. J. Gerontol. A Biol. Sci. Med. Sci. 2006 61 : 1111 18.
80. Stojilkovic SS, Vukicevic S, Luyten FP. Calcium signaling in endothelin- and platelet-derived growth factor-stimulated chondrocytes. J. Bone Miner. Res. 1994 9 : 705 14.
81. 2+ release. J. Cell Biol. 2006 174 : 639 45.
82. Yeo EJ, Jang IS, Lim HK, Ha KS, Park SC. Agonist-specific differential changes of cellular signal transduction pathways in senescent human diploid fibroblasts. Exp. Gerontol. 2002 37 : 871 83.
83. 2+ cycling proteins. Aging Cell 2006 5 : 259 65.
84. Huang MS, Adebanjo OA, Awumey E et al. IP(3), IP(3) receptor, and cellular senescence. Am. J. Physiol. Renal Physiol. 2000 278 : F576 84.
85. Kohler R, Wulff H, Eichler I et al. Blockade of the intermediate- conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 2003 108 : 1119 25.
86. + channels in proliferating A7r5 vascular smooth muscle cells. Br. J. Pharmacol. 2006 148 : 909 17.
87. 2+-binding proteins. EMBO J. 2004 23 : 312 21.
88. 2+ feedback on single cell inositol 1,4,5-trisphosphate oscillations mediated by G-protein-coupled receptors. J. Biol. Chem. 2003 278 : 20 753 60.
89. O'Brien JD, Ferguson JH, Howlett SE. Effects of ischemia and reperfusion on isolated ventricular myocytes from young adult and aged Fischer 344 rat hearts. Am. J. Physiol. Heart Circ. Physiol. 2008 294 : H2174 83.
90. 2+ homeostasis in peripheral neurones: Implications for changes in function. Aging Cell 2007 6 : 285 96.
91. Droge W, Schipper HM. Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 2007 6 : 361 70.
92. Foster TC. Calcium homeostasis and modulation of synaptic plasticity in the aged brain. Aging Cell 2007 6 : 319 25.
93. Murchison D, Griffith WH. Calcium buffering systems and calcium signaling in aged rat basal forebrain neurons. Aging Cell 2007 6 : 297 305.
94. Toescu EC, Verkhratsky A. The importance of being subtle: Small changes in calcium homeostasis control cognitive decline in normal aging. Aging Cell 2007 6 : 267 73.
95. Tanaga K, Bujo H, Zhu Y et al. LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors. Arterioscler. Thromb. Vasc. Biol. 2004 24 : 1422 8.
96. Tanaga K, Bujo H, Inoue M et al. Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler. Thromb. Vasc. Biol. 2002 22 : 662 6.
97. Seki N, Hashimoto N, Sano H et al. Mechanisms involved in the stimulatory effect of advanced glycation end products on growth of rat aortic smooth muscle cells. Metab. Clin. Exp. 2003 52 : 1558 63.
98. Wendt T, Bucciarelli L, Qu W et al. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: Insights into the pathogenesis of macrovascular complications in diabetes. Curr. Atheroscler. Rep. 2002 4 : 228 37.
99. Yan SD, Schmidt AM, Anderson GM et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 1994 269 : 9889 97.
100. Sakaguchi T, Yan SF, Yan SD et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J. Clin. Invest. 2003 111 : 959 72.
101. Stitt AW, Hughes SJ, Canning P et al. Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Diabetologia 2004 47 : 1735 46.
102. Tanii M, Yonemitsu Y, Fujii T et al. Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors. Circ. Res. 2006 98 : 55 62.
103. Schoneich C. Protein modification in aging: An update. Exp. Gerontol. 2006 41 : 807 12.
104. Kaplan-Albuquerque N, Garat C, Desseva C, Jones PL, Nemenoff RA. Platelet-derived growth factor-BB-mediated activation of Akt suppresses smooth muscle-specific gene expression through inhibition of mitogen-activated protein kinase and redistribution of serum response factor. J. Biol. Chem. 2003 278 : 39 830 8.
105. Franco CD, Hou G, Bendeck MP. Collagens, integrins, and the discoidin domain receptors in arterial occlusive disease. Trends Cardiovasc. Med. 2002 12 : 143 8.
106. Hou D, Rogers PI, Toleikis PM, Hunter W, March KL. Intrapericardial paclitaxel delivery inhibits neointimal proliferation and promotes arterial enlargement after porcine coronary overstretch. Circulation 2000 102 : 1575 81.
107. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 1995 75 : 487 517.
108. Tabibiazar R, Wagner RA, Ashley EA et al. Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease. Physiol. Genomics 2005 22 : 213 26.
109. Jones MR, Ravid K. Vascular smooth muscle polyploidization as a biomarker for aging and its impact on differential gene expression. J. Biol. Chem. 2004 279 : 5306 13.
110. George D. Targeting PDGF receptors in cancer: Rationales and proof of concept clinical trials. Adv. Exp. Med. Biol. 2003 532 : 141 51.
111. Yamasaki Y, Miyoshi K, Oda N et al. Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis. Circ. Res. 2001 88 : 630 6.
112. Zymek P, Bujak M, Chatila K et al. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J. Am. Coll. Cardiol. 2006 48 : 2315 23.
113. Nykanen AI, Krebs R, Tikkanen JM et al. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: Beneficial effects on inflammation and smooth muscle cell proliferation. Transplantation 2005 79 : 182 9.
114. Lehti K, Rose NF, Valavaara S, Weiss SJ, Keski-Oja J. MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing. J Cell. Sci. 2009 122 : 126 35.
115. Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J. LRP: Role in vascular wall integrity and protection from atherosclerosis. Science 2003 300 : 329 32.
116. Newton CS, Loukinova E, Mikhailenko I et al. Platelet-derived growth factor receptor-beta (PDGFR-beta) activation promotes its association with the low density lipoprotein receptor-related protein (LRP). Evidence for co-receptor function. J. Biol. Chem. 2005 280 : 27 872 8.
117. Swertfeger DK, Bu G, Hui DY. Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration. J. Biol. Chem. 2002 277 : 4141 6.
118. Boucher P, Li WP, Matz RL et al. LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: Implications for Marfan syndrome. PLoS ONE 2007 : 2 : e448.
119. Cacabelos R, Fernandez-Novoa L, Lombardi V, Kubota Y, Takeda M. Molecular genetics of Alzheimer's disease and aging. Methods Find. Exp. Clin. Pharmacol. 2005 27 (Suppl. A 1 573.
120. Minamino T, Komuro I. Vascular cell senescence: Contribution to atherosclerosis. Circ. Res. 2007 100 : 15 26.
121. Minamino T, Miyauchi H, Yoshida T, Tateno K, Komuro I. The role of vascular cell senescence in atherosclerosis: Antisenescence as a novel therapeutic strategy for vascular aging. Curr. Vasc. Pharmacol. 2004 2 : 141 8.